EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current and future advances in practice: aromatase inhibitor–induced arthralgia

Sara Kim, Nan Chen, Pankti Reid

Rheumatology Advances in Practice · 14.03.2024 · 8 (2)

DOI: 10.1093/rap/rkae024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 10.04.2024. Verfasst von Sara Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Chicago, Chicago, IL, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, University of Chicago Institute of Translational Medicine Clinical and Translational Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aromatase inhibitors (AIs) have shown great success as adjuvant therapy for post-menopausal women with hormone receptor–positive breast cancers. AI-induced arthralgia (AIA) is a frequent AI toxicity contributing to non-adherence and discontinuation. This review aims to understand current knowledge of AIA. The mean incidence of AIA was 39.1% and the mean discontinuation of AI therapy due to AIA was 9.3%. Most of the AIAs were non-inflammatory. A shorter time since the last menstrual period and pre-existing joint pain were risk factors. Vitamin D3 supplementation may be a preventative measure and treatment with duloxetine, acupuncture and/or exercise is supported by large randomized controlled trials. There was consistent improvement in AIAs with switching to an alternate AI, and this could additionally allow continuation of cancer treatment with AI. Further research is needed to identify predictive biomarkers, better characterize AIA subcategories and study more reliable therapeutic options.

Schlagwörter

Stichwörter der Autor:innen

aromatase inhibitoraromatase inhibitor–associated joint painarthralgiaarthritisbreast cancer

Autor:innen und Institutionen

  • Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Division of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Division of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL, USA.

Förderung

  • NCATS NIH HHS
  • University of Chicago Institute of Translational Medicine Clinical and Translational Science

Zitieren

APA

Kim, S., Chen, N., & Reid, P. (2024). Current and future advances in practice: aromatase inhibitor–induced arthralgia. Rheumatology Advances in Practice, 8(2). https://doi.org/10.1093/rap/rkae024

Vancouver

Kim S, Chen N, Reid P. Current and future advances in practice: aromatase inhibitor–induced arthralgia. Rheumatology Advances in Practice. 2024;8(2). doi:10.1093/rap/rkae024

BibTeX
@article{Kim2024,
  author = {Kim, Sara and Chen, Nan and Reid, Pankti},
  title = {Current and future advances in practice: aromatase inhibitor–induced arthralgia},
  journal = {Rheumatology Advances in Practice},
  year = {2024},
  volume = {8},
  number = {2},
  doi = {10.1093/rap/rkae024}
}
Kostenlos starten →